Lin, X., Wei, Y., Li, Y., Xiong, Y., Fang, B., Li, C., . . . Wei, J. (2022). Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways. Frontiers in Pharmacology, 13, . https://doi.org/10.3389/fphar.2022.801982
Chicago-referens (17:e uppl.)Lin, Xing, Yuanyuan Wei, Yan Li, Yuhua Xiong, Bin Fang, Cuiyu Li, Quanfang Huang, Renbin Huang, och Jinbin Wei. "Tormentic Acid Ameliorates Hepatic Fibrosis in Vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways." Frontiers in Pharmacology 13 (2022). https://doi.org/10.3389/fphar.2022.801982.
MLA-referens (9:e uppl.)Lin, Xing, et al. "Tormentic Acid Ameliorates Hepatic Fibrosis in Vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways." Frontiers in Pharmacology, vol. 13, 2022, https://doi.org/10.3389/fphar.2022.801982.
